시장보고서
상품코드
1293849

인슐린 전달 기기 시장 - 성장, 향후 전망, 경쟁 분석(2023-2031년)

Insulin Delivery Devices Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

발행일: | 리서치사: Acute Market Reports | 페이지 정보: 영문 119 Pages | 배송안내 : 1-2일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

인슐린 전달 기기는 2031년까지 6.8%의 시장 확대가 예상됩니다. 당뇨병은 전 세계적으로 관찰되는 주요 생활습관병 중 하나입니다. 전체 인슐린 전달 시장의 성장을 뒷받침하는 주요 요인은 당뇨병 유병률 증가와 당뇨병 관리 및 진단과 관련된 사회적 인식의 증가입니다. 인슐린은 다른 모든 생리학적 및 세포학적 작용의 체계적인 실행과 함께 당 수치 유지에 중요한 역할을 합니다. 전 세계적으로 당뇨병 발병이 증가하고 있는 것은 비만의 증가와 노동 인구의 좌식 생활습관 등의 요인에 기인합니다. 또한 인슐린 흡입기 및 휴대용 인슐린 펌프와 같은 새로운 인슐린 전달 기기의 기술적 업그레이드와 우월성도 인슐린 전달 기기 시장의 성장을 돕고 있습니다. 또한 시장 전문가들은 당뇨병 발병률이 특히 어린이와 성인에서 빠르게 증가하고 있으며, 이는 가까운 장래에 세계 인슐린 전달 기기 산업의 상승 요인으로 작용할 것으로 예상된다고 밝혔습니다.

인슐린 전달 기기 시장은 제품 유형에 따라 제트 인젝터, 주사기, 펌프 및 인슐린 펜으로 분류됩니다. 인슐린 주사기는 자가 투여를 위해 설계되었으며 환자의 통증을 줄여주는 짧은 바늘과 같은 많은 사용자 친화적인 기능을 갖추고 있습니다. 인슐린 펜은 인슐린 카트리지, 다이얼 및 바늘로 구성되며 주로 인슐린 투여를 위해 일회용 바늘과 함께 사용됩니다. 컴팩트한 디자인으로 인슐린 투여량을 눈에 띄지 않게 할 수 있습니다.

인슐린 전달 기기의 전체 시장 성장을 촉진하는 주요 요인은 당뇨병 관리에 대한 인식 증가, 비만, 좌식 생활습관, 신흥국에서의 조기 진단 부족 문제 등이 있습니다. 북미는 인슐린 전달 기기의 주요 지역 시장으로, 당뇨병으로 고통받는 많은 인구가 존재하고 높은 병원 비용으로 인해 당뇨병 환자가 가정 내 자가 주사를 선택하도록 강요하기 때문에 유럽이 그 뒤를 잇고 있습니다. 미국은 새로운 인슐린 전달 기기를 찾는 환자의 증가와 상환 시나리오의 지원으로 인해 인슐린 전달 기기 시장에서 가장 큰 점유율을 차지하고 있습니다. 독일, 프랑스, 영국, 캐나다 등의 국가들도 높은 성장률을 보이고 있습니다. 아시아태평양의 인슐린 전달 기기 시장은 당뇨병 환자 수가 많고 인슐린 전달의 새로운 기술에 대한 환자들의 관심이 증가함에 따라 가장 빠르게 성장하는 지역으로 간주됩니다.

목차

제1장 서문

  • 보고서 내용
    • 보고서 목적
    • 대상 독자
    • 주요 제공 상품
  • 시장 세분화
  • 조사 방법
    • 단계Ⅰ - 2차 조사
    • 단계Ⅱ - 1차 조사
    • 단계Ⅲ - 전문가 패널 리뷰
    • 가정
    • 채용한 접근법

제2장 주요 요약

제3장 인슐린 전달 기기 시장 : 경쟁 분석

  • 주요 벤더의 시장에서의 포지셔닝
  • 벤더가 채용하는 전략
  • 주요 산업 전략
  • 계층 분석 : 2022 vs 2031

제4장 인슐린 전달 기기 시장 : 거시적 분석과 시장 역학

  • 서론
  • 세계의 인슐린 전달 기기 시장 금액
  • 시장 역학
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
    • 주요 과제
    • 주요 기회
  • 성장 촉진요인과 억제요인의 영향 분석
  • See Saw 분석

제5장 인슐린 전달 기기 시장 : 유형별

  • 시장 개요
  • 성장·매출 분석 : 2022 vs 2031
  • 시장 세분화
    • 인슐린 펜
      • 재사용 가능한 펜
      • 일회용 펜
    • 인슐린 펌프
      • 기존 펌프
      • 일회용 펌프
    • 인슐린 주사기
    • 인슐린 제트 인젝터
    • 인슐린 흡입기

제6장 인슐린 전달 기기 시장 : 최종 용도별

  • 시장 개요
  • 성장·매출 분석 : 2022 vs 2031
  • 시장 세분화
    • 병원
    • 홈케어
    • 기타

제7장 북미의 인슐린 전달 기기 시장

  • 시장 개요
  • 인슐린 전달 기기 시장 : 유형별
  • 인슐린 전달 기기 시장 : 최종 용도별
  • 인슐린 전달 기기 시장 : 지역별
    • 북미
      • 미국
      • 캐나다
      • 기타 북미

제8장 영국과 유럽연합의 인슐린 전달 기기 시장

  • 시장 개요
  • 인슐린 전달 기기 시장 : 유형별
  • 인슐린 전달 기기 시장 : 최종 용도별
  • 인슐린 전달 기기 시장 : 지역별
    • 영국과 유럽연합
      • 영국
      • 독일
      • 스페인
      • 이탈리아
      • 프랑스
      • 기타 유럽

제9장 아시아태평양의 인슐린 전달 기기 시장

  • 시장 개요
  • 인슐린 전달 기기 시장 : 유형별
  • 인슐린 전달 기기 시장 : 최종 용도별
  • 인슐린 전달 기기 시장 : 지역별
    • 아시아태평양
      • 중국
      • 일본
      • 인도
      • 호주
      • 한국
      • 기타 아시아태평양

제10장 라틴아메리카의 인슐린 전달 기기 시장

  • 시장 개요
  • 인슐린 전달 기기 시장 : 유형별
  • 인슐린 전달 기기 시장 : 최종 용도별
  • 인슐린 전달 기기 시장 : 지역별
    • 라틴아메리카
      • 브라질
      • 멕시코
      • 기타 라틴아메리카

제11장 중동 및 아프리카의 인슐린 전달 기기 시장

  • 시장 개요
  • 인슐린 전달 기기 시장 : 유형별
  • 인슐린 전달 기기 시장 : 최종 용도별
  • 인슐린 전달 기기 시장 : 지역별
    • 중동 및 아프리카
      • GCC
      • 아프리카
      • 기타 중동 및 아프리카

제12장 기업 개요

  • Novo Nordisk A/S
  • Sanofi
  • Eli Lilly and Company
  • Biocon Ltd.
  • Ypsomed AG
  • Wockhardt Ltd.
  • Medtronic
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
ksm 23.07.05

Insulin Delivery Devices Market is Expected to Grow at 6.8% by 2031. Diabetes is one of the leading lifestyle diseases observed across the world. The key factors assisting the overall growth of the insulin delivery market are the mounting prevalence of diabetes and rising public awareness related to diabetes management and diagnostics. Insulin plays vital role in maintenance of sugar levels along with the systematic execution of all other physiological and cellular actions. The growing incidence of diabetes around the world is observed due to factors such as the increasing prevalence of obesity, and practice of sedentary lifestyle in the working population. In addition, technological upgradation and superiority in the novel insulin delivery devices such as insulin inhaler and portable insulin pumps are also assisting the market growth of insulin delivery devices market. Market experts also suggested that the disease incidence rate of diabetes is rapidly increasing especially in children and adults, which is expected to be the boosting factor for global insulin delivery devices industry in the near future.

The insulin delivery devices market on the basis of product type is segmented into jet injectors, syringes, pumps and insulin pens. Insulin syringes are designed for self-administration of doses and have many user-friendly features such as short needles which reduce pain in patients. Insulin pen comprises insulin cartridge, dial and a needle; primarily used with disposable needles for the delivery of insulin doses. The compact design of these devices allows discreet administration of insulin.

The key drivers assisting the overall market growth of insulin delivery devices are increasing awareness related to diabetes management, and mounting issues related to obesity, sedentary lifestyle, and lack of early diagnosis in developing countries. North America is the leading regional market for insulin delivery devices and is trailed by Europe due to the existence of a large population suffering with diabetes, and high hospital expenses are forcing diabetes patients to opt for self-injections for home use. The U.S. attributed the largest share for the insulin delivery devices market due to rising patient's inclination towards novel insulin delivery devices and supportive reimbursement scenario. Other countries such as Germany, France, U.K. and Canada are also witnessing high growth in the market. Asia-Pacific insulin delivery devices market was observed as the fastest-growing region due to the presence of large pool of diabetes patients and the rising accessibility of patients towards novel technologies in insulin delivery.

Key Players Identified for Insulin Delivery Devices Market Include but are Not Limited to:

  • Novo Nordisk A/S
  • Sanofi
  • Eli Lilly and Company
  • Biocon Ltd.
  • Ypsomed AG
  • Wockhardt Ltd.
  • Medtronic
  • Abbott Laboratories
  • F. Hoffmann-La Roche, Ltd.

Historical & Forecast Period

This study report represents an analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends, and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. A key data point that enables the estimation of Insulin Delivery Devices market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Insulin Delivery Devices market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approaches for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Segmentation

Type

  • Insulin Pen
    • Reusable Pen
    • Disposable Pen
  • Insulin Pump
    • Traditional Pump
    • Disposable Pump
  • Insulin Syringes
  • Insulin Jet Injectors
  • Insulin Inhalers

End-use

  • Hospitals
  • Homecare
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Insulin Delivery Devices market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Insulin Delivery Devices market?
  • Which is the largest regional market for Insulin Delivery Devices market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Insulin Delivery Devices market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Insulin Delivery Devices market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Insulin Delivery Devices Market
  • 2.2. Global Insulin Delivery Devices Market, By Type, 2022 (US$ Million)
  • 2.3. Global Insulin Delivery Devices Market, By End-use, 2022 (US$ Million)
  • 2.4. Global Insulin Delivery Devices Market, By Geography, 2022 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2022

3. Insulin Delivery Devices Market: Competitive Analysis

  • 3.1. Market Positioning of Key Insulin Delivery Devices Market Vendors
  • 3.2. Strategies Adopted by Insulin Delivery Devices Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Insulin Delivery Devices Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Insulin Delivery Devices Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Insulin Pen
      • 5.3.1.1. Reusable Pen
      • 5.3.1.2. Disposable Pen
    • 5.3.2. Insulin Pump
      • 5.3.2.1. Traditional Pump
      • 5.3.2.2. Disposable Pump
    • 5.3.3. Insulin Syringes
    • 5.3.4. Insulin Jet Injectors
    • 5.3.5. Insulin Inhalers

6. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Hospitals
    • 6.3.2. Homecare
    • 6.3.3. Others

7. North America Insulin Delivery Devices Market, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
  • 7.3. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
  • 7.4.Insulin Delivery Devices Market: By Region, 2021-2031, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 7.4.1.1.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 7.4.1.2.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 7.4.1.3.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)

8. UK and European Union Insulin Delivery Devices Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
  • 8.3. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
  • 8.4.Insulin Delivery Devices Market: By Region, 2021-2031, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.1.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.2.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.3.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.4.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.5.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.6.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)

9. Asia Pacific Insulin Delivery Devices Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
  • 9.3. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
  • 9.4.Insulin Delivery Devices Market: By Region, 2021-2031, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.1.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.2.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.3.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.4.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.5.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.6.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)

10. Latin America Insulin Delivery Devices Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
  • 10.3. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
  • 10.4.Insulin Delivery Devices Market: By Region, 2021-2031, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 10.4.1.1.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 10.4.1.2.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 10.4.1.3.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)

11. Middle East and Africa Insulin Delivery Devices Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
  • 11.3. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
  • 11.4.Insulin Delivery Devices Market: By Region, 2021-2031, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 11.4.1.1.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 11.4.1.2.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Insulin Delivery Devices Market: By Type, 2021-2031, USD (Million)
        • 11.4.1.3.1. Insulin Delivery Devices Market: By End-use, 2021-2031, USD (Million)

12. Company Profile

  • 12.1. Novo Nordisk A/S
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Sanofi
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Eli Lilly and Company
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Biocon Ltd.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Ypsomed AG
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Wockhardt Ltd.
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Medtronic
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Abbott Laboratories
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. F. Hoffmann-La Roche, Ltd.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제